Eli Lilly reports outcomes from Phase III trial of tirzepatide for HFpEF
The trial met both primary endpoints, with tirzepatide showing a 38% decrease in heart failure outcomes compared to placebo.
Eli Lilly and Novo want to shake off Ozempic copycats. Are they ready to meet demand?
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
Newstalk2h
The end of obesity? New treatment cuts body weight by 23%
New medication that can cut body weight by 23% could radically reduce the number of people who are obese. Tirzepatide is ...
The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy
In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...
NJBIZ1h
Pharma giants defend against high-stakes lawsuit over weight loss drugs
Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...
We’ll all be taking Ozempic-type drugs ‘like we do daily vitamins’
Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...
Diabetes and weight loss drugs shown to reduce alcohol-related hospitalizations, study finds
Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why diabetes and weight loss drugs work better than alcohol medications.
Hundreds dead, thousands infected in Sudan's months-long cholera outbreak
Hundreds of people are dead and thousands infected in Sudan's months-long cholera outbreak. A recent statistic from the ...